🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 26818M108
- Market Cap
- Large Cap · $1 Billion
- IPO
- 9/17/2020 · $19.00/share
Business: Dyne Therapeutics, Inc. is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates.
Company Contact
- CEO
- Joshua Brumm
- VPF
- Gene Kim
- Headquarters
- 830 Winter Street, Waltham, MA 02451
- Phone
- 781-786-8230
- Investor Relations
- Amy Reilly · 857-341-1203 · areilly@dyne-tx.com